Clinical Trial Update: Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT [NA]

View source ↗

Summary

This clinical trial (NCT07319793) sponsored by Peking University People's Hospital is evaluating pre-DLI or pro-DLI approaches in relapsed or refractory myeloid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Peking University People's Hospital | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes (MDS) | NA | Status: NOT_YET_RECRUITING